| Page 1820 | Kisaco Research
 

Brian Burke

Head of Strategy
Horizon Discovery

Brian joined Horizon in 2012 during which time he has led various functions including Sales, Business Development and Product Management.  Much of his career has been focused in driving both the NGS and gene editing revolutions, most notably in the fields of diagnostics and bioprocessing.  In 2018 he was promoted to the Global Head of Strategy and now leads Horizon’s Corporate Development efforts including strategy development and M&A. 

Brian Burke

Head of Strategy
Horizon Discovery

Brian Burke

Head of Strategy
Horizon Discovery

Brian joined Horizon in 2012 during which time he has led various functions including Sales, Business Development and Product Management.  Much of his career has been focused in driving both the NGS and gene editing revolutions, most notably in the fields of diagnostics and bioprocessing.  In 2018 he was promoted to the Global Head of Strategy and now leads Horizon’s Corporate Development efforts including strategy development and M&A. 

 

Bruno Cluzel

Executive Director, International Operations, Diagnostics Customer Care
Zoetis

Bruno Cluzel is Executive Director, International Operations, Diagnostics Customer Care for Zoetis. In this role, he is responsible to define guidelines for customer and technical support services delivered in the markets; deliver elevated technical support and instrument repair; provide guidance to the Diagnostic Application Specialists in-market technical support; and develop and help deliver training curriculum, materials and sessions.

Bruno Cluzel

Executive Director, International Operations, Diagnostics Customer Care
Zoetis

Bruno Cluzel

Executive Director, International Operations, Diagnostics Customer Care
Zoetis

Bruno Cluzel is Executive Director, International Operations, Diagnostics Customer Care for Zoetis. In this role, he is responsible to define guidelines for customer and technical support services delivered in the markets; deliver elevated technical support and instrument repair; provide guidance to the Diagnostic Application Specialists in-market technical support; and develop and help deliver training curriculum, materials and sessions.

Bruno has extensive experience working within the animal health care sector. Through his career, Bruno has held various roles working across a number of different functions and regions.  

With a passion for animal health, Bruno holds a diploma of Veterinary Medicine and started his career as a Practitioner specialized in Production Animal with a focus on Avian Medicine. After 15 years in this role, he joined Merial where he had different roles across Europe Africa and Middle East: technical, marketing and business lead. He joined Pfizer Animal Health in 2011 to help entering the Diagnostics. In his current role, he is building Customer Care capabilities as Zoetis expands around the Globe.

 

Dr. Julie Horvath

Head of the Genomics & Microbiology Research Lab at the North Carolina Museum of Natural Sciences AND jointly appointed Research Associate Professor at North Carolina Central University
North Carolina Central University

Dr. Julie Horvath is a comparative evolutionary genomicist interested in understanding the evolutionary forces that have shaped primate genomes and that cause human disease. Genetic and genomic comparisons between humans and our closest relatives, the primates, are crucial for understanding our own evolution and unique characteristics. The foundation of Dr. Horvath’s research is based on species relationships, or phylogenies, which she first established for lemurs, and more recently, for all primates. These species relationships are applied to many of her research questions.

Dr. Julie Horvath

Head of the Genomics & Microbiology Research Lab at the North Carolina Museum of Natural Sciences AND jointly appointed Research Associate Professor at North Carolina Central University
North Carolina Central University

Dr. Julie Horvath

Head of the Genomics & Microbiology Research Lab at the North Carolina Museum of Natural Sciences AND jointly appointed Research Associate Professor at North Carolina Central University
North Carolina Central University

Dr. Julie Horvath is a comparative evolutionary genomicist interested in understanding the evolutionary forces that have shaped primate genomes and that cause human disease. Genetic and genomic comparisons between humans and our closest relatives, the primates, are crucial for understanding our own evolution and unique characteristics. The foundation of Dr. Horvath’s research is based on species relationships, or phylogenies, which she first established for lemurs, and more recently, for all primates. These species relationships are applied to many of her research questions. Several examples of Horvath’s research investigate the connection between genotype (DNA sequence) and phenotype (traits and characteristics) that make flora and fauna unique. 

 

Jonathan Gilbert

Global Commercial Lead Microbiome GI Health
Nestlé Health Science

Jonathan Gilbert

Global Commercial Lead Microbiome GI Health
Nestlé Health Science

Jonathan Gilbert

Global Commercial Lead Microbiome GI Health
Nestlé Health Science
 

Craig Thomson

Partner & Patent Attorney
HGF Limited

Craig has considerable experience in providing pragmatic, commercially focused advice to a wide-range of clients and in relation to biotechnological and pharmaceutical fields.  As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, preparing for or carrying out funding/acquisition due diligence, and advising on aggressive/defensive strategies in relation to third party IP. He has a particular interest in inventions relating to the microbiome, including bacteriophage.

Craig Thomson

Partner & Patent Attorney
HGF Limited

Craig Thomson

Partner & Patent Attorney
HGF Limited

Craig has considerable experience in providing pragmatic, commercially focused advice to a wide-range of clients and in relation to biotechnological and pharmaceutical fields.  As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, preparing for or carrying out funding/acquisition due diligence, and advising on aggressive/defensive strategies in relation to third party IP. He has a particular interest in inventions relating to the microbiome, including bacteriophage.

 

Artem Khlebnikov

Strategic Partnerships Director
Danone Nutricia Research

Artem Khlebnikov is Strategic Partnerships Director at the Danone Nutricia Research. In his role, he works closely with public and private partners and Danone R&I colleagues brining open innovation  to help drive science-based opportunities that activate the Danone’s alimentation strategy and enable significant and sustainable growth opportunities aligned with Danone’s #OneHealth.OnePlanet approach.

Artem Khlebnikov

Strategic Partnerships Director
Danone Nutricia Research

Artem Khlebnikov

Strategic Partnerships Director
Danone Nutricia Research

Artem Khlebnikov is Strategic Partnerships Director at the Danone Nutricia Research. In his role, he works closely with public and private partners and Danone R&I colleagues brining open innovation  to help drive science-based opportunities that activate the Danone’s alimentation strategy and enable significant and sustainable growth opportunities aligned with Danone’s #OneHealth.OnePlanet approach.

Artem holds an MS degree in Chemical Engineering from the Mendeleev University of Chemical Technology, Moscow Russia, has completed his PhD in Biotechnology at the Swiss Federal institute of Technology in Lausanne and received Post-Doctoral training in Molecular Biology at University of California at Berkeley, USA.

 

Peter Sweetbaum

CEO
IT Lab

As an experienced CEO and executive within the technology sector, Peter brings along leadership, strategic guidance and entrepreneurial skills. Peter has a legal and corporate finance background and was Senior Technology Adviser within the HM Cabinet Office.

Peter Sweetbaum

CEO
IT Lab

Peter Sweetbaum

CEO
IT Lab

As an experienced CEO and executive within the technology sector, Peter brings along leadership, strategic guidance and entrepreneurial skills. Peter has a legal and corporate finance background and was Senior Technology Adviser within the HM Cabinet Office.

 

James Dening

Automation Anywhere

James Dening

Automation Anywhere

James Dening

Automation Anywhere
 

James Murray

James Murray

James Murray

Poster Abstract Booklet